CBD Policy & Regulation Related News
Regulation and reputation with Medicinal Cannabis Industry Australia
Rosemary Richards of Medicinal Cannabis Industry Australia tells MCN about industry regulation, licensing and the future of Australian cannabis.
Medicinal Cannabis Industry Australia (MCIA), the...
Medical Cannabis Network Quarterly Issue 2
Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our second edition, which looks at cannabis research, policy and innovation around the world.
Welcome to the...
Marijuana Policy Project: state level policy reform, what’s next?
Marijuana Policy Project Communications Manager Violet Cavendish explores the growing push for adult use legalisation in Arizona.
The Marijuana Policy Project (MPP) is the nation’s...
New Zealand’s Medical Cannabis Scheme now launched
New Zealand has now launched its Medical Cannabis Scheme that will help patients gain better access to cannabis medicines.
As of April 1, 2020, New...
The ACI launches new CBD safety certification initiative
The Association for the Cannabinoid Industry (The ACI) today outlined new plans for The ACI CBD Safety Certification programme.
The Association for the Cannabinoid Industry...
CBD at the crossroads: a response to the FSA guidelines
Professor Mike Barnes, co-founder of Maple Tree Consultants, responds to the FSA's guidelines regarding CBD products.
As the cannabis market has grown exponentially over the...
Arge Canna: medical cannabis lobbying and patient advocacy in Austria
Mag. Klaus Hübner of patient advocacy body Arge Canna tells MCN about Austria’s medical cannabis legislation and Arge Canna’s campaigns.
Arge Canna is the primary...
The NCIA talks policy, equality and regulation in US cannabis
National Cannabis Industry Association Media Relations Director Morgan Fox tells MCN about regulation, policy reform and representation in the field of US cannabis.
The National...
New poll finds overwhelming public support for FSA CBD regulation
A new YouGov poll commissioned by The Association for the Cannabinoid Industry (The ACI) demonstrates overwhelming support for recent FSA guidance concerning CBD and...
Calls for CBD regulation following inaccurate CBD levels on products
The Digital Citizens Alliance is calling on Congress for CBD regulation as new research has highlighted the inaccuracy of CBD potency levels listed on...
Dana Rohrabacher on evolving cannabis policy in America
Former Republican politician, Dana Rohrabacher, has been a long-time advocate of medical cannabis in America. Here, Medical Cannabis Networks discusses evolving cannabis policy in...
Illicit-vape deaths highlight urgency of legalising cannabis
A report has highlighted how the vape death crisis underscores the importance and urgency of legalising cannabis nationwide.
According to the report Cannabis Vaping: Opportunities...
Three reasons the Conservative government might legalise cannabis
In this article Ian Hamilton of the University of York and Harry Sumnall of Liverpool John Moores University discuss three reasons why the Conservative...
Study reveals difference between labelled and actual CBD potency
A scientific study has revealed differences between the CBD potency labelled on products and actual potency when measured.
GemmaCert has revealed the results of a...
ProPharma: seven things to consider in medical cannabis development
ProPharma Group takes a look at medical cannabis regulation and compliance.
Jan Zorgdrager, PhD, and Marc Stegeman, MSc, Principal Consultants in ProPharma Group’s Life Sciences...
B3 Labs responds to FSA CBD deadline announcement
Last week The Food Standards Agency (FSA) formally issued a definitive timeline for Novel Food applications setting a deadline for the 31 March 2021...
CannaPro: the only solution for CBD is a cannabis regulation authority
Following the issuing of the Food Standards Agency’s (FSA) CBD safety advice, a UK cannabis body, CannaPro, has suggested that the solution for the...
Reforming cannabis policy on a state and federal level in the USA
The US-based Marijuana Policy Project aims to ease the burden on patients by campaigning for effective, workable policy reform.
The Marijuana Policy Project (MPP), founded...
The Conservative Drug Policy Reform Group: driving reform in the UK
The Conservative Drug Policy Reform Group weighs in on the current situation surrounding access to cannabis-based medicines in the UK.
The Conservative Drug Policy Reform...
FSA issues first ever CBD safety advice and sets deadline for businesses
The Food Standards Agency (FSA) has issued its first ever CBD safety advice for consumers, and a stark warning to manufacturers.
Today the FSA has...
